Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today announced the grant and/or allowance of a series of patents and patent applications. These patents and patent applications, which were granted/allowed in 2020 and 2021, are expected to provide broad protection for Brainstorm’s proprietary NurOwn® (MSC-NTF cells) technology in territories including the U.S., E.U., Canada, Israel and Hong Kong.
BC Craft Stock Slumps After Canadian Cannabis Company Files For Protection From Creditors
BC Craft Supply Co (OTCMKTS: CRFTF), a British Columbia-based wellness company advancing cannabinoid and psychedelic innovation, filed for temporary protection from creditors under Canada’s Bankruptcy and Insolvency Act while the cannabis company restructures.
